HDGFL2 and malaria: The target antigens in current commercially available malaria RDTs are histidine-rich protein 2 (HRP2), specific for Plasmodium falciparum (Pf), and the parasite enzymes lactate dehydrogenase (pLDH) and aldolase, present in all Plasmodium species infective to humans [5].